356 related articles for article (PubMed ID: 24090961)
21. Oral contraceptives and neoplasia.
Lancet; 1983 Oct; 2(8356):947-8. PubMed ID: 6138506
[TBL] [Abstract][Full Text] [Related]
22. Weighing the evidence on the pill and breast cancer.
Johnson JH
Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
[TBL] [Abstract][Full Text] [Related]
23. [Oral contraceptives: recent safety studies (author's transl)].
Edgren RA
Contracept Fertil Sex (Paris); 1983 Sep; 11(9):975-83. PubMed ID: 12279633
[TBL] [Abstract][Full Text] [Related]
24. Cancer of the breast and reproductive tract in relation to use of oral contraceptives.
Schlesselman JJ
Contraception; 1989 Jul; 40(1):1-38. PubMed ID: 2673658
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptive agents and breast cancer: a population-based case-control study.
Rohan TE; McMichael AJ
Med J Aust; 1988 Nov; 149(10):520-6. PubMed ID: 3185321
[TBL] [Abstract][Full Text] [Related]
26. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
Gross TP; Schlesselman JJ
Obstet Gynecol; 1994 Mar; 83(3):419-24. PubMed ID: 8127536
[TBL] [Abstract][Full Text] [Related]
27. Long-term health risks and benefits of oral contraceptive use.
Peterson HB; Lee NC
Obstet Gynecol Clin North Am; 1990 Dec; 17(4):775-88. PubMed ID: 2092241
[TBL] [Abstract][Full Text] [Related]
28. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
29. Oral contraceptives and breast cancer: a cooperative Italian study.
La Vecchia C; Negri E; Franceschi S; Talamini R; Amadori D; Filiberti R; Conti E; Montella M; Veronesi A; Parazzini F
Int J Cancer; 1995 Jan; 60(2):163-7. PubMed ID: 7829209
[TBL] [Abstract][Full Text] [Related]
30. Neoplasia and hormonal contraception.
Huggins GR
Clin Obstet Gynecol; 1981 Sep; 24(3):903-25. PubMed ID: 7026111
[TBL] [Abstract][Full Text] [Related]
31. The pill and cancer: a review of the literature. A case of swings and roundabouts?
Knowlden HA
J Adv Nurs; 1990 Sep; 15(9):1016-20. PubMed ID: 2229699
[TBL] [Abstract][Full Text] [Related]
32. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
[TBL] [Abstract][Full Text] [Related]
33. Oral contraceptives and cancer of the reproductive organs.
Huezo C
IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511
[TBL] [Abstract][Full Text] [Related]
34. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
35. Oral contraceptives and cervical cancer--further findings from the Oxford Family Planning Association contraceptive study.
Zondervan KT; Carpenter LM; Painter R; Vessey MP
Br J Cancer; 1996 May; 73(10):1291-7. PubMed ID: 8630295
[TBL] [Abstract][Full Text] [Related]
36. OCs and genital tract malignancies.
Herbst AL
Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
[TBL] [Abstract][Full Text] [Related]
37. Update on cancer risk and oral contraceptives.
Engel NS
MCN Am J Matern Child Nurs; 1990; 15(1):37. PubMed ID: 2105427
[TBL] [Abstract][Full Text] [Related]
38. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
39. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
40. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
